Gonadotropin-releasing hormone agonists: utilization before hysterectomy.
Stovall
T G
TG
Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, North Carolina 27157-1066.
D000740:Anemia / Q000097:blood / Q000150:complications / Q000188:drug therapy; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D003613:Danazol / Q000627:therapeutic use; D004334:Drug Administration Schedule; D005260:Female; D005867:Gestrinone / Q000627:therapeutic use; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007044:Hysterectomy / Q000009:adverse effects / Q000379:methods; D058085:Iron Compounds / Q000627:therapeutic use; D007889:Leiomyoma / Q000150:complications / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery*; D011300:Preoperative Care; D011372:Progestins / Q000627:therapeutic use; D014594:Uterine Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery*
D058085:Iron Compounds; D011372:Progestins; D005867:Gestrinone; D007987:Gonadotropin-Releasing Hormone; D003613:Danazol